A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid

NCT04672954 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: 2.5 milligram (mg) BI 474121
DRUG: 10 milligram (mg) BI 474121
DRUG: 20 milligram (mg) BI 474121
DRUG: 40 milligram (mg) BI 474121

Sponsor

Boehringer Ingelheim